Faculty of Medicine, University of Toronto, Toronto, Canada.
Division of Dermatology, University of Toronto, Toronto, Canada.
Inflamm Res. 2017 Nov;66(11):931-945. doi: 10.1007/s00011-017-1074-y. Epub 2017 Jun 27.
Hidradenitis suppurativa (HS) is a painful chronic inflammatory disease with a prevalence between 1 and 4% of general population. The pathogenesis of HS long eluded scientists, but growing evidence suggests that it is a consequence of inflammatory dysregulation.
Recent studies suggest that dysregulated immune response to skin flora and overexpression of inflammatory cytokines leads to chronic skin inflammation seen in HS. Macrophages are the most numerous inflammatory cells found in HS infiltrates and release numerous pro-inflammatory cytokines such as IL-23, and IL-1β and TNF-α, exacerbating the inflammation and contributing to the pathogenesis of HS. Furthermore, in HS, there is dysregulated function of other immune players closely associated with macrophage function including: matrix metalloproteases (MMP) 2 and 9 overexpression, toll-like receptor upregulation, impaired Notch signalling, NLRP3 inflammasome upregulation, and dysregulated keratinocyte function. Lifestyle factors including obesity and smoking also contribute to macrophage dysfunction and correlate with HS incidence.
The overexpression of pro-inflammatory cytokines and subsequent efficacy of anti-cytokine biologic therapies highlights the importance of managing macrophage dysfunction. Future therapies should target key molecular drivers of macrophage dysfunction such as TLR2 and NLRP3 overexpression.
化脓性汗腺炎(HS)是一种疼痛的慢性炎症性疾病,其普通人群的患病率在 1%至 4%之间。HS 的发病机制长期以来一直困扰着科学家,但越来越多的证据表明,它是炎症失调的结果。
最近的研究表明,对皮肤菌群的免疫反应失调和炎症细胞因子的过度表达导致 HS 中所见的慢性皮肤炎症。巨噬细胞是 HS 浸润中数量最多的炎症细胞,释放许多促炎细胞因子,如 IL-23、IL-1β 和 TNF-α,从而加重炎症并促进 HS 的发病机制。此外,在 HS 中,与巨噬细胞功能密切相关的其他免疫细胞的功能也失调,包括:基质金属蛋白酶(MMP)2 和 9 的过度表达、 Toll 样受体上调、Notch 信号受损、NLRP3 炎性体上调以及角质形成细胞功能失调。生活方式因素,包括肥胖和吸烟,也会导致巨噬细胞功能障碍,并与 HS 的发病率相关。
促炎细胞因子的过度表达以及随后的抗细胞因子生物疗法的疗效突出了管理巨噬细胞功能障碍的重要性。未来的治疗方法应针对 TLR2 和 NLRP3 过度表达等巨噬细胞功能障碍的关键分子驱动因素。